Nonhematopoietic stem cells of fetal origin--how much of today's enthusiasm will pass the time test?
Stem cells originating at fetal age are for many reasons superior as a material for the regenerative medicine purposes, when compared to their adult counterparts. While hematopoietic cells, isolated from fetal liver or cord blood, have been well known for a long time and have passed practical tests...
Main Authors: | Eugeniusz K Machaj, Tomasz Ołdak, Zygmunt Pojda, Agnieszka Gajkowska, Marzena Jastrzewska |
---|---|
Format: | Article |
Language: | English |
Published: |
Via Medica
2005-12-01
|
Series: | Folia Histochemica et Cytobiologica |
Online Access: | http://czasopisma.viamedica.pl/fhc/article/view/4598 |
Similar Items
-
Differentiation potential of the fetal rat liver-derived cells.
by: Zygmunt Pojda, et al.
Published: (2005-12-01) -
Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells in leukapheresis product and bone marrow for clinical transplantation: a comparison of three methods.
by: E Kraszewska, et al.
Published: (2006-04-01) -
Mesenchymal Stem Cell Therapy in Nonhematopoietic Diseases
by: Katherine Athayde Teixeira de Carvalho, et al.
Published: (2015-01-01) -
Chimeric antigen receptor T-cell therapy in hematopoietic and nonhematopoietic malignancies
by: Faizan Ahmad
Published: (2020-01-01) -
Nonhematopoietic IRAK1 drives arthritis via neutrophil chemoattractants
by: André, C., et al.
Published: (2022)